Showing results (131-140 of 2,258) with videos related to
Sort By:
Pageof 226
Progress in Cardiovascular Diseases|August 6, 2019
Mechanistic insights regarding the role of SGLT2 inhibitors and GLP1 agonist drugs on cardiovascular disease in diabetesVinay Garg, Subodh Verma, Kim ConnellyCurrent Opinion in Cardiology|January 6, 2016
Update on rheumatic heart diseaseBobby Yanagawa, Jagdish Butany, Subodh VermaCurrent Opinion in Cardiology|January 28, 2016
Year in review: mitral valve surgeryBobby Yanagawa, David Latter, Subodh VermaCurrent Opinion in Cardiology|December 22, 2018
Early failure of aortic bioprostheses: what are the mechanisms?Amine Mazine, Subodh Verma, Bobby YanagawaDiabetologia|August 23, 2018
SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art reviewSubodh Verma, John J V McMurrayThe Canadian Journal of Cardiology|February 10, 2015
Obesity and atherosclerosis: mechanistic insightsFina Lovren, Hwee Teoh, Subodh VermaAmerican Journal of Physiology. Heart and Circulatory Physiology|December 22, 2023
Aldosterone and aldosterone synthase inhibitors in cardiorenal diseaseSubodh Verma, Avinash Pandey, Arjun K Pandey, et al.The Lancet. Digital Health|December 17, 2020
Artificial intelligence in medical imaging: switching from radiographic pathological data to clinically meaningful endpointsOhad Oren, Bernard J Gersh, Deepak L BhattCleveland Clinic Journal of Medicine|August 18, 2006
Using statins to treat inflammation in acute coronary syndromes: Are we there yet?Mehdi H Shishehbor, Taral Patel, Deepak L BhattExpert Opinion on Drug Safety|July 13, 2021
Icosapent ethyl: safely reducing cardiovascular risk in adults with elevated triglyceridesManan Pareek, R Preston Mason, Deepak L BhattPageof 226